| 期 |
栏目 |
标题 |
文件 |
| 卷 8, 编号 7 (2022) |
Articles |
Neuropsychiatric disorders of non-alcoholic fatty liver disease |
|
| 卷 9, 编号 7 (2023) |
REVIEWS |
Perspectives of use outside diabetes, cardiac and nephroprotection |
|
| 卷 10, 编号 3 (2024) |
LECTURES & REPORTS |
Chemopreventive and anti-tumor potential of ademetionine in case of chronic hepatic disorders |
|
| 卷 10, 编号 4 (2024) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Gliflozins as remedies for correction of neurological complications of non-alcoholic fatty liver disease. Part 1 |
|
| 卷 10, 编号 5 (2024) |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Gliflozins as remedies for correction of non-alcoholic fatty liver disease neurological complications. Part 2 |
|
| 卷 10, 编号 9 (2024) |
LECTURES & REPORTS |
Phenomenon of aging liver. Part I: Molecular-genetic, cellular, and tissue mechanisms |
|
| 卷 11, 编号 2 (2025) |
LECTURES & REPORTS |
Patient compliance with medical recommendations: Realities and perspectives |
|
